Amedisys, Inc. (NASDAQ:AMED) Given Consensus Rating of “Hold” by Analysts
Shares of Amedisys, Inc. (NASDAQ:AMED – Get Free Report) have earned an average recommendation of “Hold” from the five ratings firms that are currently covering the company, MarketBeat.com reports. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1-year target price […]
Shares of Amedisys, Inc. (NASDAQ:AMED – Get Free Report) have earned an average recommendation of “Hold” from the five ratings firms that are currently covering the company, MarketBeat.com reports. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1-year target price […]
